Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
about
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@en
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@nl
type
label
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@en
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@nl
prefLabel
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@en
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@nl
P2093
P2860
P356
P1476
Thirty-Day Readmissions in Hos ...... ostridium difficile Infection.
@en
P2093
Alison Pedley
Mary Beth Dorr
Mary E Hanson
Oliver A Cornely
Sebastian M Heimann
Stephen Marcella
Vimalanand S Prabhu
Yoav Golan
P2860
P304
P356
10.1093/CID/CIX523
P407
P577
2017-08-11T00:00:00Z